Carefree Panty Liners Lawsuit: Women Sue Edgewell, Essity and J&J Over Alleged PFOA

No class action over Carefree liners has been reported. The suit reported in October 2026 is a personal injury case in which hundreds of women bring their own claims in one complaint in Los Angeles County Superior Court. It has no certified class, no settlement and no claim form. An earlier 2024 case, Ecological Alliance v. Edgewell, was a Proposition 65 warning-label suit brought by an environmental group, not a class action, and it was dismissed without prejudice in January 2025.

Researchers who test period products describe two routes. PFAS can be added on purpose, usually to make a layer resist moisture, or they can end up in a product unintentionally through treated raw materials, packaging or manufacturing equipment. Notre Dame researchers who screened more than 100 period and incontinence products found fluorine, a marker for PFAS, in about half of them, and some pads and period underwear had levels high enough to suggest intentional use. No peer-reviewed study of Carefree liners specifically has been published; the PFOA allegation comes from testing cited by the plaintiffs and by an environmental group in a 2024 notice.

PFAS are built on carbon–fluorine bonds, among the strongest in chemistry, which makes surfaces treated with them repel water, oil and stains and resist breaking down. In a pad, liner or pair of period underwear that translates into a leak barrier that keeps fluid from wicking through to clothing. The same stability is why PFAS persist in the environment and in the human body for years. Products made without PFAS exist, which is why California chose to ban intentionally added PFAS in menstrual products starting January 1, 2025.

It depends on the chemical. The World Health Organization’s cancer agency, IARC, classified PFOA as carcinogenic to humans (Group 1) in November 2023, citing sufficient evidence in animals, strong mechanistic evidence and limited human evidence linking PFOA to kidney and testicular cancer. It classified PFOS as possibly carcinogenic (Group 2B). California has listed PFOA under Proposition 65 as a developmental toxicant since 2017 and as a carcinogen since 2022. Most of the thousands of other PFAS have not been evaluated. A hazard classification does not establish that any particular product caused any particular person’s illness, which is a question courts decide case by case.

Laboratory research suggests some can. A 2024 University of Birmingham study published in Environment International applied 17 PFAS to lab-grown 3D human skin models and found that 15 were absorbed at meaningful levels; about 13.5% of the PFOA dose passed through and another 38% stayed in the skin. The study used tissue models rather than living people, so it shows a possible exposure route, not measured uptake from any product. The Carefree plaintiffs allege absorption through vulvar tissue, which a court has not evaluated.

Essity, the Swedish hygiene company, has owned Carefree in North America since February 2, 2026, when it closed its $340 million purchase of Edgewell Personal Care’s North American feminine care business. Edgewell, which was spun off from Energizer in 2015, held the brand from October 2013, when Energizer bought Carefree, Stayfree and o.b. in North America from Johnson & Johnson for $185 million. Johnson & Johnson kept the brand outside North America, a business now owned by Kenvue.

No recall of Carefree panty liners appears in the FDA medical device recall database as of October 13, 2026. Menstrual pads and liners are regulated by the FDA as medical devices. The only recent recalls under the Carefree name in that database involve an unrelated surgical-supply company.